THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 116 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $152,587 | -15.9% | 17,681 | +0.9% | 0.00% | – |
| Q2 2023 | $181,342 | -26.3% | 17,521 | -22.7% | 0.00% | -100.0% |
| Q1 2023 | $245,980 | -3.3% | 22,671 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $254,369 | -5.1% | 22,671 | -14.3% | 0.00% | 0.0% |
| Q3 2022 | $268,000 | +11.7% | 26,461 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $240,000 | -5.1% | 26,461 | 0.0% | 0.00% | – |
| Q1 2022 | $253,000 | -13.4% | 26,461 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $292,000 | +49.0% | 26,461 | 0.0% | 0.00% | – |
| Q3 2021 | $196,000 | -49.0% | 26,461 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $384,000 | -22.3% | 26,461 | +9.3% | 0.00% | 0.0% |
| Q1 2021 | $494,000 | -2.4% | 24,208 | -14.9% | 0.00% | 0.0% |
| Q4 2020 | $506,000 | +20.2% | 28,458 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $421,000 | -29.5% | 28,458 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $597,000 | -9.3% | 28,458 | 0.0% | 0.00% | -50.0% |
| Q1 2020 | $658,000 | -10.7% | 28,458 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $737,000 | +31.8% | 28,458 | -0.8% | 0.00% | +100.0% |
| Q3 2019 | $559,000 | +19.2% | 28,698 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $469,000 | -27.6% | 28,698 | +0.4% | 0.00% | -50.0% |
| Q1 2019 | $648,000 | -11.4% | 28,578 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $731,000 | -21.7% | 28,578 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $934,000 | +44.1% | 28,578 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $648,000 | +4.9% | 28,578 | +12.2% | 0.00% | 0.0% |
| Q1 2018 | $618,000 | -13.1% | 25,478 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $711,000 | -18.5% | 25,478 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $872,000 | -14.1% | 25,478 | 0.0% | 0.00% | -33.3% |
| Q2 2017 | $1,015,000 | +8.2% | 25,478 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $938,000 | +15.5% | 25,478 | 0.0% | 0.00% | +50.0% |
| Q4 2016 | $812,000 | -12.0% | 25,478 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $923,000 | +59.7% | 25,478 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $578,000 | +24.6% | 25,478 | +3.3% | 0.00% | 0.0% |
| Q1 2016 | $464,000 | +14.9% | 24,663 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $404,000 | +49.1% | 24,663 | 0.0% | 0.00% | +100.0% |
| Q3 2015 | $271,000 | -15.0% | 24,663 | +0.6% | 0.00% | 0.0% |
| Q2 2015 | $319,000 | -22.9% | 24,513 | +2.7% | 0.00% | 0.0% |
| Q1 2015 | $414,000 | +16.3% | 23,869 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $356,000 | -35.3% | 23,869 | 0.0% | 0.00% | -50.0% |
| Q3 2014 | $550,000 | -60.0% | 23,869 | -44.6% | 0.00% | -50.0% |
| Q2 2014 | $1,374,000 | – | 43,092 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |